236 
Market Cap
Stock Chart
GeneticTech - 30 Day Poll
Recent BLOGS About GeneticTech Add New
Latest Company News
|
Will Mayo v. Prometheus Fire Up Pharma?: Kevin DeGeeter
BioMedReports (subscription) - May 16, 2012 By George S. Mack of The Life Sciences Report Newly discovered biomarkers could provide physicians with information that will aid in the diagnosis and treatment of disease.
|
|
Will Mayo v. Prometheus Fire Up Pharma?: Kevin DeGeeter
InvestorIdeas.com (press release) - May 11, 2012 May 11, 2012 (Investorideas.com Newswire) Newly discovered biomarkers could provide physicians with information that will aid in the diagnosis and treatment of disease.
Will <i>Mayo v. Prometheus</i> Fire Up Pharma?: Kevin DeGeeter - Jutia Group |
|
GTG signs settlement, licensing agreement with GeneSeek
Pharmaceutical Business Review - May 10, 2012 Genetic Technologies (GTG) has signed a settlement and license agreement with GeneSeek of Lincoln, Nebraska, USA. As per the agreement, GeneSeek gained certain non-exclusive rights to a number of GTG patents relating to its non-coding DNA technology.
|
|
Genetic Technologies Executes Settlement and License Agreement With GeneSeek Inc.
MarketWatch (press release) - May 9, 2012 MELBOURNE, AUSTRALIA, May 09, 2012 (MARKETWIRE via COMTEX) -- In compliance with ASX Continuing Disclosure Rules, Genetic Technologies Limited (asx:GTG) (UTD:GENE) is pleased to report that it has executed a Settlement and License Agreement with ...
GENETIC TECHNOLOGIES LIMITED : Settlement with GeneSeek - 4-traders |
|
Genetic Technologies Executes Settlement and License Agreement With GeneSeek Inc.
Marketwire (press release) - May 9, 2012 MELBOURNE, AUSTRALIA--(Marketwire - May 9, 2012) - In compliance with ASX Continuing Disclosure Rules, Genetic Technologies Limited ( ASX : GTG) ( NASDAQ : GENE) is pleased to report that it has executed a Settlement and License Agreement with GeneSeek ...
Genetic Technologies Executes Settlement And License Agreement With GeneSeek - NASDAQ |
|
Genetic Technologies Ltd Executes Settlement and License Agreement With GeneSeek Inc
Reuters Key Development - May 9, 2012 |
|
Personalized Women's Healthcare of Plano Pioneers Breast Cancer Risk Assessment
MarketWatch (press release) - Apr 30, 2012 PLANO, Texas, Apr 30, 2012 (BUSINESS WIRE) -- Dr. Eric Jacoby of Personalized Women's Healthcare is one of the first physicians in the nation to make the BREVAGen(TM) predictive risk test available to his patients.
|
|
Genetic Technologies Ltd Concludes Second Patent Infringement Suit In USA
Reuters Key Development - Feb 21, 2012 |
Website
Videos related to GeneticTech
Company Profile
Genetic Technologies (ASX: GTG, NASDAQ Global Market: GENE) is a genetic testing and reproductive services business which, together with a range of international patents and allied research activities, aims at uncovering the impact of DNA on health. The Company’s principal activities include the provision of genetic testing services and canine reproductive services.
Throughout the Asia Pacific region, they translate specialised genetic tests into products and services that optimise the health knowledge and outcomes in humans, animals and plants.
A strong patetnt position?
They have filed a patent infringement suits against nine U.S. biotechnology companies, including Bechman Coulter and Monsanto (Tier 1 organizsations). The patent at the centre of the suit refers to non-coding DNA technologies that Genetic Technologies claims are being used by the biotech firms without license. The counter-parties in the suit are Beckman Coulter, Orchid Cellmark, Gen-Probe, Interleukin Genetics, Molecular Pathology Laboratory Network, Monsanto, PIC USA, Sunrise Medical Laboratories and Pioneer Hi-Bred International. The non-coding DNA technology in question is already licensed to 39 other companies.
In 2008 Genetic Technologies stirred up controversy by demanding several Australian labs cease performing a test for the breast cancer genes BRCA1 and BRCA2 for which the company held an exclusive license. Genetic Technologies later withdrew the threat and allowed testing for the genes to continue. The company has been successful in other patent infringement suits, such as in 2005 against Applera Corporation (now ABI Biosystems).
Total revenue and income ($m)
2006: $10.39
2007: $10.76
2008: $15.32
2009: $15.98 (net loss after tax $7.86M)